Article

AMO's Tecnis CL replaces company's other silicone IOL models

Advanced Medical Optics Inc. (AMO) launched its Tecnis CL silicone IOL, which reduces spherical aberrations, improves functional vision, and improves night-driving simulator performance. This IOL replaces the company’s Z9000 and Z9001 Tecnis silicone IOL models.

Advanced Medical Optics Inc. (AMO) launched its Tecnis CL silicone IOL, which reduces spherical aberrations, improves functional vision, and improves night-driving simulator performance. This IOL replaces the company’s Z9000 and Z9001 Tecnis silicone IOL models.

The Tecnis CL IOL was introduced last month at the European Society of Cataract and Refractive Surgery meeting in London. AMO will begin shipping the lens this month in the United States, Canada, and Asia Pacific, and to Japan by mid-2007.

The blue-modified C PMMA haptics provide better visibility and easier implantation of the lens, and the frosted OptiEdge design reduces edge glare and posterior capsule opacification, according to the company.

The new IOL can be implanted with the Unfolder Silver Series Implantation Systems and the Silver Advance Cartridge through a 2.8-mm incision.

“The Tecnis CL IOL provides the same FDA-approved claims and excellent outcomes as the original Tecnis lens but with a more user-friendly design,” said AMO Corporate Vice President and Chief Marketing Officer Russ Trenary. “We expect the Tecnis CL to speed surgeon migration from older-generation silicone lenses to the superior Tecnis optical design.”

In August, the Centers for Medicare and Medicaid Services extended New Technology Intraocular Lens status to the Tecnis CL lens.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.